CD44 and breast carcinoma: In the basal-likeMDA-MB-231 breast cancer cell model, the subpopulation of CD44 (+) CD24 (low+) cells exhibits stem cell properties in vitro and in vivo, metastatic gene signatures and greater invasion and metastatic potential.